Selected patients with metastatic melanoma may benefit from liver resection

World Journal of Surgery

Volumn 31, Issue 1, 2007, Pages 171-174

  Herman, Paulo ^a,b,c   Machado, Marcel Autran C ^a   Montagnini, André Luis ^a   D'Albuquerque, Luiz A C ^b   Saad, William A ^b   Machado, Marcel C C ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BILE DUCT FISTULA; CANCER SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; DISEASE FREE INTERVAL; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; INOPERABLE CANCER; LIVER METASTASIS; LIVER RESECTION; MALE; MELANOMA; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PERITONEUM METASTASIS; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; EYE NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; PATIENT SELECTION; PERITONEAL NEOPLASMS; SKIN NEOPLASMS;

EID: 33846125300     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-006-0375-z     Document Type: Article

References (18)

1. Elias D, Albuquerque AC, Eggenspieler P, et al. Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients. J Am Coll Surg 1998;187:487-493.
2. Hemming AW, Sielaff TD, Gallinger S, et al. Hepatic resection of noncolorectal nonneuroendocrine metastases. Liver Transpl 2000;6:97-101.
3. Weitz J, Blumgart LH, Fong Y, et al. Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma. Ann Surg 2005;241:269-276.
4. Laurent C, Rullier E, Feyler A, et al. Resection of noncolorectal and nonneuroendocrine liver metastases: late metastases are the only chance of cure. World J Surg 2001;25:1532-1536.
5. Rose DM, Essner R, Hughes TMD, et al. Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg 2001;136:950-955.
6. Salmon RJ, Levy C, Plancher C, et al. Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapy. Eur J Surg Oncol 1998;24:127-130.
7. Mondragon-Sanchez R, Barrera-Franco JL, Cordoba-Gutierrez H, et al. Repeat hepatic resection for recurrent metastatic melanoma. Hepatogastroenterology 1999;46:459-461.
8. Hsueh EC, Essner R, Foshag LJ, et al. Prolonged survival after complete resection of metastases from intraocular melanoma. Cancer 2004;100:122-129.
9. Wong SL, Coit DG. Role of surgery in patients with stage IV melanoma. Curr Opin Oncol 2004;16:155-160.
10. Allen PJ, Coit DG. The surgical management of metastatic melanoma. Ann Surg Oncol 2002;9:762-770.
11. Branum GD, Epstein RE, Leight GS, et al. The role of resection in the management of melanoma metastatic to the adrenal gland. Surgery 1991;109:127-131.
12. Mosimann F, Fontolliet C, Genton A, et al. Resection of metastases to the alimentary tract from malignant melanoma. Int Surg 1982;67:257-260.
13. Lejeune FJ, Lienard D, Sales F, et al. Surgical management of distant melanoma metastases. Semin Surg Oncol 1992;8:381-391.
14. Wong JH, Euhus DM, Morton DL. Surgical resection for metastatic melanoma to the lung. Arch Surg 1988;123:1091-1095.
15. De Wilt JHW, McCarthy WH, Thompson JF. Surgical treatment of splenic metastases in patients with melanoma. J Am Coll Surg 2003;197:38-43.
16. Foster JH. Survival after liver resection for secondary tumors. Am J Surg 1978;135:389-394.
17. Stas M, Stroobants S, Dupont P. 18-FDG PET scan in the staging of recurrent melanoma: additional value and therapeutic impact. Melanoma Res 2002;12:479-490.
18. Clark PB, Victoria Soo BS, Kraas J, et al. Futility of fluorodeoxyglucose F-18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma. Arch Surg 2006;141:284-288.